Corneal cross-linking was approved by United States Food and Drug Administration for the treatment of progressive keratoconus in April 2016. As this approach becomes more widely used for the treatment of keratoconus and post-laser in situ keratomileusis (LASIK) ectasia, the medical community is becoming more familiar with potential complications associated with this procedure. This article aims to review the reported complications of collagen cross-linking for the treatment of keratoconus and post-LASIK ectasia.
机构:
Albert Ludwig Univ Freiburg, Univ Freiburg, Med Ctr, Eye Ctr, Freiburg, GermanyAlbert Ludwig Univ Freiburg, Univ Freiburg, Med Ctr, Eye Ctr, Freiburg, Germany
Maier, Philip
论文数: 引用数:
h-index:
机构:
Reinhard, Thomas
Kohlhaas, Markus
论文数: 0引用数: 0
h-index: 0
机构:
St Johannes Hosp, Dept Ophthalmol, Dortmund, GermanyAlbert Ludwig Univ Freiburg, Univ Freiburg, Med Ctr, Eye Ctr, Freiburg, Germany